Purpose: To compare visual outcomes and aberration outcomes in small incision lenticule extraction (SMILE) versus femtosecond laser LASIK (FS-LASIK). Methods: This prospective, comparative, nonrandomized clinical study included 68 eyes of 37 patients receiving SMILE and 55 eyes of 30 patients receiving FS-LASIK between December 2011 and January 2013 at the Fudan University Eye and ENT Hospital (Shanghai, People's Republic of China). Patients were followed up at 3, 6 months and 5 years after surgery. Main outcome measurements included uncorrected (UDVA) and corrected (CDVA) distance visual acuity, manifest refraction, central corneal thickness (CCT), total corneal refractive power (TCRP) and wavefront aberrations. Results: About 98% (49/50) of treated eyes in the SMILE group and 95% (39/41) in the FS-LASIK group had a postoperative logMAR UDVA of 0 or better. Spherical equivalent (SE) after 5 years was À0.01 AE 0.35 D in the SMILE group and À0.23 AE 0.41 D in the FS-LASIK group. A regression of À0.02 AE 0.39 D in the SMILE group and À0.12 AE 0.32 D in the FS-LASIK group was observed between 6 months and 5 years postoperative time-points. TCRP increased by 0.39 AE 0.38 D in the SMILE group and 0.45 AE 0.49 D in the FS-LASIK group between 6-month and 5-year time-points. However, no statistically significant difference was found between the SMILE and FS-LASIK groups in terms of ΔSE, ΔCCT and ΔTCRP between 6 months and 5 years postoperative time-points. Conclusion: Myopic regression was observed in terms of TCRP but not in subjective refraction. No statistically significant difference in stability was found between SMILE and FS-LASIK.
Introduction
Femtosecond laser small incision lenticule extraction (SMILE), first reported in 2011, is a relatively new technique for the correction of myopia and myopic astigmatism (Sekundo et al. 2011; Shah et al. 2011) . The procedure has been well demonstrated in terms of efficacy, safety, stability and predictability, with published followup periods of up to 5 years; it has thus gained worldwide acceptance (Pedersen et al. 2015; Blum et al. 2016; Hansen et al. 2016; Zhang et al. 2016; Kobashi et al. 2018; Qin et al. 2018) .
However, long-term outcome data for SMILE are needed to further improve our understanding of this relatively new procedure. So far, there have been several reports on efficacy and safety of SMILE with 2-year (Kobashi et al. 2018) , 3-year (Pedersen et al. 2015) , 4-year (Han et al. 2016) , and 5-year (Blum et al. 2016 ) outcome data. However, to the best of our knowledge, there is no long-term visual outcome data comparing SMILE versus femtosecond laser LASIK (FS-LASIK).
In the current study, we aim to compare 5-year outcomes of SMILE and FS-LASIK for myopia and myopic astigmatism correction in terms of visual outcomes and aberration.
Patients and Methods

Patients
A total of 67 consecutive patients undergoing SMILE or FS-LASIK procedures for the treatment of myopia at the Fudan University Eye and ENT Hospital (Shanghai, People's Republic of China) were recruited between December 2011 and January 2013. All patients underwent either SMILE or FS-LASIK procedures. The inclusion criteria for both procedures were as follows: age 18 years or older, an otherwise normal ophthalmic examination and a stable refractive error with a minimum calculated residual corneal stromal bed thickness greater than 280 lm. Patients with spherical refractive error up to À10.0 D and astigmatism up to À5.0 D cyl were included (Table 1) .
The Ethical Committee of the Fudan University EENT Hospital Review Board approved the study protocol, and the study was conducted in accordance with the principles of the Declaration of Helsinki. Each patient provided written informed consent after a full explanation of the risks and benefits of the study. The surgeon made the decision of whether treatment was indicated. Each patient then chose which of the two procedures to undergo after the surgeon fully explained the two procedures.
Surgical technique
The VisuMax femtosecond laser system (Carl Zeiss Meditec AG, Jena, Germany) in standard mode was used to perform the SMILE procedure. In all eyes, the S-size contact glass was used. The laser settings were set to a repetition rate of 500 kHz and pulse energy of 130 nJ. A spot distance of 2.5 lm was used for the lenticule cut and cap cut, and a spot distance of 2.0 lm was used for the lenticule sidecut and cap side-cut. The exact procedure technique was as described in our previous study (Li et al. 2014) . The attempted treatment centre was the corneal vertex. The corneal cap thickness was 100 lm. The target lenticule diameter (optical zone) was set to 6.5-6.8 mm, depending on the preoperative corneal thickness and the refractive error to be corrected. The tissue arcade diameter was set to 1 mm larger than the diameter of the lenticule. The side cuts made for access to the lenticule were set 90°apart with a circumferential width of 2.0-4.5 mm.
In the FS-LASIK group, flaps were created with a 500 kHz VisuMax femtosecond laser. The created flaps had diameters of 8.0 mm, with standard 90°hinges and 90°side-cut angles. The lamellar and side cuts were performed with energies of 185 nJ. The intended flap thickness was 90 lm. The hinges were set at a superior orientation with a hinge length of 4.0 mm. Stromal tissue ablation was performed with the MEL-80 (Carl Zeiss Meditec) excimer laser with a repetition rate of 250 Hz. Patients wore bandage soft contact lenses (ACUVE OASYS Inc., Jacksonville, FL, USA) for 1 day after surgery.
The same surgeon (XZ) performed all procedures. Postoperative topical medication regimens were identical for both groups and consisted of the administration of an ophthalmic solution of levofloxacin four times per day for 7 days, a 0.1% fluorometholone solution tapered from 8 to 1 times per day over the course of 24 days and a tear supplement four times per day for 1 month.
Main outcome measures
The following parameters were evaluated in all patients before surgery and at 3, 6 months and 5 years after surgery.
(1) Slit-lamp examination and intraocular pressure (2) Uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) using standard logarithmic visual acuity charts (3) Objective and manifest refraction, axial length (4) Corneal thickness (CCT), total corneal refractive power (TCRP) and wavefront aberrations. Corneal thickness (CCT), TCRP and wavefront aberrations were acquired by corneal topography (Pentacam, Oculus GmbH, Wetzlar, Germany). Pentacam imaging was performed by the same experienced examiner for all subjects at all visits. Only scans registered as 'OK' by the examination quality indicator on the instrument were saved and analysed.
Corneal power was acquired from the TCRP map, which is automatically calculated by the PENTACAM software (56) 41 (75) FS-LASIK = femtosecond laser LASIK, SMILE = small incision lenticule extraction.
and reported in the power distribution display. The TCRP map uses ray tracing to calculate corneal power, and the calculation is based on Snell's law of refraction using real refractive indices (1 for air, 1.376 for the cornea and 1.336 for aqueous humour). Values are shown by diameters ranging from 1.0 to 8.0 mm and are calculated on a ring or over a circular area (zone), centred on either the corneal apex or the pupil centre. In this study, TCRP was analysed in a zone of 3 mm from the apex. The corneal wavefront aberrations of the anterior surface were analysed over a 6.0 mm central diameter. ) and highorder aberrations (HOAs) from the third to sixth order were analysed, as these are most clinically significant for visual quality.
ΔSE, ΔCCT, ΔTCRP and Δaberra-tions were defined as the difference in SE, CCT, TCRP and aberrations, respectively, between two visits.
Statistical analysis
Data were analysed using SAS 9.3 statistical software (SAS Institute Inc., Cary, NC, USA). Continuous variables were expressed as the mean AE standard deviation (SD), while categorical variables were expressed as frequency and percentage. A linear mixed model was constructed to assess the SE, CCT, TCRP and aberrations within each group. This method was also used to compare the ΔSE, ΔCCT, ΔTCRP and Δaberrations between the SMILE group and the FS-LASIK group, adjusting for preoperative SE at baseline. A p-value less than 0.05 was considered statistically significant.
Results
The number of eyes evaluated at each examination time-point is shown in Table 2 . Seventy-five per cent of the patients were followed for the full 5 years.
Efficacy
The cumulative percentage of UDVA at 5 years postop is presented in Fig. 1 . In the SMILE group, 98% (49/50) of eyes had a postoperative logMAR UDVA of 0 or better, compared to 95% (39/41) in the FS-LASIK group. In both SMILE and FS-LASIK groups, 100% of eyes had a postoperative logMAR UDVA of 0.10 or better.
Ninety per cent (45/50) of eyes in the SMILE group had a UDVA equal to or better than CDVA, as compared to 88% (36/41) in the FS-LASIK group (Fig. 2) .
Safety
At 5-year follow-up, 24% (12/51) of SMILE-treated eyes and 24% (10/41) of FS-LASIK-treated eyes gained two lines of CDVA. No eyes lost two or more lines of CDVA in either group (Fig. 3) . Fig. 1 . Five years postoperative cumulative uncorrected distance visual acuity after small incision lenticule extraction and femtosecond laser LASIK for myopia. For one eye, the target refraction was not plano, and this eye was therefore excluded from this analysis. Fig. 2 . Five years postoperative uncorrected distance visual acuity versus corrected distance visual acuity after small incision lenticule extraction (A) and femtosecond laser LASIK (B) for myopia. For one eye, the target refraction was not plano, and this eye was therefore excluded from this analysis.
One participant in the FS-LASIK group reported frequent stinging in her right eye until 2 years postoperatively, which was diagnosed as dry eye. No other severe complications were observed during the follow-up period.
Predictability
A scatter plot of the attempted versus achieved spherical equivalent (SE) correction after 5 years is shown in Fig. 4 (Fig. 5) .
Astigmatism correction
Refractive astigmatism is shown in Fig. 6 . Mean 5-year refractive astigmatism was À0.26 AE 0.23 DC (range: À0.75 to 0 DC) in the SMILE group and À0.29 AE 0.27 DC (range: À1.00 to 0 DC) in the FS-LASIK group. About 96% (49/51) of eyes in SMILE group and 93% (38/41) of eyes in FS-LASIK group were within AE0.5 DC. A scatter plot of the target-induced astigmatism (TIA) versus the surgically induced astigmatism (SIA) after 5 years is shown in Fig. 7 . Nine per cent (4/44) of eyes in the SMILE group and 8% (3/ 37) of eyes in the FS-LASIK group showed an angle of error (degrees) <À15°, 11% (5/44) of eyes in SMILE group and 3% (1/37) of eyes in FS-LASIK group presented angle of error (degrees) >15° (Fig. 8) . preoperative and postoperative readings in both groups, as would be expected following surgery (p < 0.001). Throughout the 6 months to 5 years postoperative period, CCT showed an increasing trend in both groups (p < 0.0001), with no statistically significant difference observed between the two groups (p = 0.57; Fig. 9B ).
In both SMILE and FS-LASIK groups, the 6 months postoperative TCRP of the 3 mm diameter corneal ring showed no statistically significant difference compared to 3-month values (SMILE: p = 0.06; FS-LASIK: p = 0.42). Between 6 months and 5 years postoperative time-points, TCRP increased by 0.39 AE 0.38 D (range: À0.45 to 1.25) in the SMILE group and 0.45 AE 0.49 D (range: À0.65 to 1.4 D) in the FS-LASIK group (p < 0.01 in both groups). However, no statistically significant difference in ΔTCRP was found between SMILE and FS-LASIK groups in the 6 months to 5 years postoperative period (p = 0.74) or in the 3-month to 5 years postoperative period (p = 0.11; Fig. 9C ). Table 3 shows the individual components of aberration after both SMILE and FS-LASIK procedures.
Wavefront aberration
At 5 years postoperatively, coma, spherical aberration and HOA increased significantly compared to preoperative values in both groups (all p < 0.0001). For the SMILE group, coma and HOA were higher at 6-month follow-up than at 3-month follow-up with p = 0.02 and p = 0.007, respectively, then remained stable from 6 months to 5 years postoperatively (p = 0.14 for coma, and p = 0.39 for HOA). The spherical aberration in the SMILE group remained stable from 3 months to 5 years postoperatively (p > 0.05). In the FS-LASIK group, coma, spherical aberration and HOA all remained stable from 3 months to 5 years postoperatively (all p > 0.05).
Comparing the Δaberrations from before surgery to 5 years postoperatively, no significant difference in ΔHOA was found between the two procedures (p = 0.13); however, the Δcoma in SMILE was greater than that in FS-LASIK (p = 0.007) over the same period. In contrast, the Δspheri-cal aberration was lower in the SMILE group than in the FS-LASIK group (p < 0.0001).
Comparing Δaberrations from 6-month to 5-year follow-up, no significant difference was found between the two procedures with respect to the Δcoma or spherical aberration (p = 0.15 for coma, p = 0.11 for spherical aberration); however, the ΔHOA in SMILE was greater than that in FS-LASIK (p = 0.03).
Discussion
Several studies have compared the visual outcomes in SMILE and FS-LASIK with varying follow-up periods (Lin et al. 2014; Moshirfar et al. 2015; Liu et al. 2016) . A comparative prospective study by Lin et al. (2014) showed efficacy indices of 0.99 and 1.04 for SMILE at 1 and 3 months postoperatively, compared to efficacy indices of 1.02 and 1.10 for FS-LASIK at 1 and 3 months (n = 111 eyes). Liu et al. (2016) compared outcomes of SMILE (n = 113 eyes) versus FS-LASIK (n = 84 eyes) and found no statistically significant difference in UDVA or spherical equivalent refraction at 6 months postoperatively. Similarly, in a systemic review of 2002 SMILEtreated eyes and 35 498 LASIK-treated eyes, SMILE and FS-LASIK were found to have similar efficacy in myopic correction (Moshirfar et al. 2015) . Consistent with these studies, we found similar efficacy between SMILE and FS-LASIK procedures at 5 years. . Five years postoperative spherical equivalent refraction after small incision lenticule extraction and femtosecond laser LASIK for myopia. For one eye, the target refraction was not plano, and this eye was therefore excluded from this analysis. In terms of safety, Blum et al. (2016) found that CDVA (logMAR) improved over time after SMILE from 0.02 at 1 month postoperatively to À0.12 after 5 years, although no statistical significance was found (p = 0.186). Pedersen et al. (2015) reported that CDVA (logMAR) improved from À0.05 AE 0.15 at 3 months postoperatively to À0.08 AE 0.11 at 3 years (p < 0.001) after SMILE, and no eyes lost two or more lines of CDVA. Han et al. (2016) found that no eye lost any Snellen lines, and 9% of eyes showed an increase of two lines at 4 years after SMILE with a safety index of 1.16 AE 0.14. Our study likewise showed that no eyes lost two or more lines of CDVA, further demonstrating that the long-term safety of SMILE is favourable and that both SMILE and FS-LASIK are very safe. These results are further corroborated by previous studies showing similar safety in SMILE and FS-LASIK at 3 months to 1 year postoperatively (Lin et al. 2014; Moshirfar et al. 2015; Liu et al. 2016 ).
Long-term stability is of great importance in corneal refractive surgeries, especially when considering a relatively new procedure (Moshirfar et al. 2015) . In Pedersen et al.'s (2015) study, mean SEs were À0.31 AE 0.53 D after 3 months and À0.39 AE 0.61 D after 3 years for SMILE, with no statistical difference observed (p = 0.071). However, significant myopic regression was observed in terms of TCRP with an average of 0.36 AE 0.29 D between 3 months and 3 years postoperatively. The observed change in TCRP was thought to be too minor to influence the subjective refractive SE. Likewise, in this study we found no statistically significant myopic regression in terms of SE in either SMILE or FS-LASIK patients. Though we found that TCRP increased significantly in both groups between 6-month and 5-year follow-up, there was no statistically significant difference between the FS-LASIK and SMILE groups. Pedersen et al.'s (2015) long-term study of SMILE, observed a regression of À0.08 D from 3 months to 3 years after SMILE. Blum et al. (2016) found the 5-year refraction after SMILE was À0.375 D, corresponding to a regression of 0.48 D. The authors' further analysis identified seven eyes that largely accounted for the overall regression. Among these seven eyes, one eye had a cap perforation with a resultant corneal scar and subsequent corneal steepening; the other six eyes showed growth in the axial length. When these seven eyes were excluded, the average regression was 0.278 D. In long-term studies of LASIK, Zalentein et al. (2009) reported a regression of À0.97 D from 2 months to 7-8 years after LASIK in 38 eyes. Alio et al. (2015) reported a regression rate of À0.12 D per year after LASIK with stabilization from 2 to 5 years in 40 high myopic eyes (À6.00 to À18.00 D). Sekundo et al. (2003) reported a regression of À0.63 D from 1 to 6 years after LASIK in 33 eyes with high and very high preoperative refraction (mean SE: À13.65 D). In comparison, we observed a regression of À0.02 and À0.12 D in SMILE and FS-LASIK, respectively, from 6 months to 5 years postoperatively. The markedly lower regression in our study compared to previous LASIK studies is likely attributable to the lower degree of myopia in patients included in this study.
We also found no difference in regression between the SMILE and FS-LASIK groups. This finding is consistent with a prior retrospective case-control study by Kobashi et al. (2018) , which found a regression of À0.10 and À0.23 D for SMILE and LASIK, respectively, from 3 months to 2 years, but no statistically significant difference between the groups (n = 30 eyes in each group).
In terms of corneal wavefront aberrations, SMILE-treated eyes induced less spherical aberration and more coma than FS-LASIK-treated eyes. Similar results were reported by others (Lin et al. 2014; Liu et al. 2016; Wu & Wang 2016) . In addition, in SMILEtreated eyes, coma and HOA remained stable from 6 months to 5 years postoperatively, and spherical aberration remained stable from 3 months to 5 years postoperatively. Partially consistent with our study, Pedersen et al. (2015) reported that coma remained stable, but spherical aberration and HOA significantly decreased from 3 months to 3 years postoperatively. This difference may be explained by the high myopia population studied by Pedersen et al., and the more significant long-term corneal remodelling in high myopia patients. Ivarsen & Hjortdal (2012) reported that spherical aberration, coma and HOA remained stable from 1 month to 7 years after LASIK, which is consistent with our finding that corneal wavefront aberrations remained stable from 3 months to 5 years postoperatively.
One limitation of this study is that there is not a randomized sample and is subject to selection bias that may result in an unbalanced selection of patients. Also, the sample size is not large, and future studies with a larger sample size are needed. In addition, differences in energy setting and cap/flap thickness may have effects on the refractive results; these are important considerations for the design of future studies.
In summary, this study is the first comparison of long-term outcomes in SMILE versus FS-LASIK for correction of myopia. The two procedures were found to have similar efficacy, safety, predictability and stability.
